Immunotherapy has made remarkable strides in cancer therapy over the past decade.
However, such emerging therapy still suffers from the low response rates and immune …

Cancer immunotherapy effect can be greatly enhanced by other methods to induce
immunogenic cell death (ICD), which has profoundly affected immunotherapy as a highly …

Immunomodulation of tumor‐associated macrophages (TAMs) into tumor‐inhibiting M1‐like
phenotype is a promising but challenging strategy. Cleverly, tumor cells overexpress CD47 …

Reactive oxygen species (ROS) are crucial signaling molecules that can arouse immune
system. In recent decades, ROS has emerged as a unique therapeutic strategy for malignant …

Despite recent advancements in cancer immunotherapy, challenges have yet to be
surmounted to achieve two major goals of magnifying antitumor immunity and remodeling …

The advent of immunotherapy has marked a new era in cancer treatment, offering significant
clinical benefits. Cell membrane as drug delivery materials has played a crucial role in …

As a modern biomedical therapeutic modality, sonodynamic therapy (SDT) presents unique
advantages, including superior tissue penetration capability, temporal–spatial controllability …

Cancer immunotherapy is restricted to immune resistance caused by immunosuppressive
tumor microenvironment. Pyroptosis involved in antitumor immunotherapy as a new …

Although nano-immunotherapy has advanced dramatically in recent times, there remain two
significant hurdles related to immune systems in cancer treatment, such as (namely) …

Pyroptosis-based nanomedicine shows great potential to unchoke the bottlenecks of cancer
immunotherapy, but hindered by precise and specific regulation of pyroptosis in tumor cells …